162 related articles for article (PubMed ID: 35807252)
1. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design.
Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of ketoprofen dissolution rate by the liquisolid technique: optimization and in vitro and in vivo investigations.
Devi S; Kumar S; Verma V; Kaushik D; Verma R; Bhatia M
Drug Deliv Transl Res; 2022 Nov; 12(11):2693-2707. PubMed ID: 35178670
[TBL] [Abstract][Full Text] [Related]
4. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
5. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique.
Venkateswarlu K; Preethi JK; Chandrasekhar KB
Adv Pharm Bull; 2016 Sep; 6(3):385-390. PubMed ID: 27766222
[No Abstract] [Full Text] [Related]
7. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
[TBL] [Abstract][Full Text] [Related]
8. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
Hentzschel CM; Sakmann A; Leopold CS
Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
[TBL] [Abstract][Full Text] [Related]
9. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
[TBL] [Abstract][Full Text] [Related]
10. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
Khanfar M; Sheikh Salem M; Hawari R
Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
[TBL] [Abstract][Full Text] [Related]
11. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
[TBL] [Abstract][Full Text] [Related]
12. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties.
Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410
[TBL] [Abstract][Full Text] [Related]
13. Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.
Patel DS; Pipaliya RM; Surti N
Indian J Pharm Sci; 2015; 77(3):290-8. PubMed ID: 26180274
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan.
Chella N; Narra N; Rama Rao T
J Drug Deliv; 2014; 2014():692793. PubMed ID: 25371826
[TBL] [Abstract][Full Text] [Related]
15. Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design.
Vittal GV; Deveswaran R; Bharath S; Basavaraj B; Madhavan V
Int J Pharm Investig; 2012 Jul; 2(3):150-6. PubMed ID: 23373006
[TBL] [Abstract][Full Text] [Related]
16. In vitro release evaluation of hydrocortisone liquisolid tablets.
Spireas S; Sadu S; Grover R
J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of dissolution rate of indomethacin: using liquisolid compacts.
Saeedi M; Akbari J; Morteza-Semnani K; Enayati-Fard R; Sar-Reshteh-Dar S; Soleymani A
Iran J Pharm Res; 2011; 10(1):25-34. PubMed ID: 24363677
[TBL] [Abstract][Full Text] [Related]
18. Liquisolid systems to improve the dissolution of furosemide.
Akinlade B; Elkordy AA; Essa EA; Elhagar S
Sci Pharm; 2010; 78(2):325-44. PubMed ID: 21179350
[TBL] [Abstract][Full Text] [Related]
19. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
Kamble PR; Shaikh KS; Chaudhari PD
Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of liquisolid compacts of diclofenac sodium.
Kulkarni AS; Gaja JB
PDA J Pharm Sci Technol; 2010; 64(3):222-32. PubMed ID: 21502022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
